Reduce Risk for Crohn's Disease Patients

NCT02852694 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

192

Enrollment

OTHER

Sponsor class

Conditions

Crohn's Disease

Interventions

DRUG: Methotrexate
DRUG: Adalimumab
DRUG: Azathioprine / 6 Mercaptopurine

Sponsor

PIBD-Net

Collaborators

[object Object]